Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsVirus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSVNewcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccinePriming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeCD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse.Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors.Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvantProtection against respiratory syncytial virus by a recombinant Newcastle disease virus vectorGamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragmentDevelopment of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus.Protective and dysregulated T cell immunity in RSV infectionRecombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced DiseaseNonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels.Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced DiseasesCharacteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of AgeNeed for a safe vaccine against respiratory syncytial virus infection.Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.Universal vaccine against respiratory syncytial virus A and B subtypes.A role for immune complexes in enhanced respiratory syncytial virus disease.Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus.Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PSingle intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infectionCharacterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.
P2860
Q26775152-EA2F38CB-A13E-4AF5-878B-28DD37A2EA0BQ28764574-9A67E905-CA41-4E42-A74D-754A231F16E0Q30442832-168A9D28-AE61-407C-84BB-A0556CDC89F1Q30448968-B3D2213B-DEFA-4D01-A7BC-7C42A1E5F144Q33558475-7624D455-C20D-4B4E-B7DB-2468868DA827Q33648461-5A4A4847-3EB0-4FB3-BA44-733C0295035EQ33781642-1BB10BD6-5114-4C9C-85AE-9B256E8C9CC7Q33783066-E58C8290-3DA4-4FAF-BA10-72983482C57DQ33801890-F65341C1-15FC-4FA5-ADCC-69D9B1319EE4Q33807265-B880A716-74B1-4B85-A536-51AA3A079F8AQ33820420-1D5D5C45-5EDD-45F5-8057-649A41895BCCQ33848810-214712D4-0428-4179-B818-660139C4E36CQ33870105-6E65A1C6-D8FA-4526-BD81-C906F9F19B4FQ34057901-348B5756-558A-4EDF-B9BB-FAEB8C4B1DFBQ34082711-60F80DBC-AB28-4286-8A6E-4EB90CDEE4CAQ34151000-58AE3674-F32A-4A77-B836-E283D0D3731DQ34151865-DC30B095-C7BD-4090-BD11-C679FF66AD47Q34182385-42F37BC9-E882-42A8-BCB4-F50FADE5E17CQ34302198-7BEF4315-EDF9-4567-AC48-1831DF4E12DAQ34347904-D0FC0D1A-C42D-4D00-A931-1C747413AA69Q34624688-F61268A2-4AE9-4CB0-A7AB-F5844E5A40A8Q34964939-8081E5F0-0D87-4F19-AFC8-100F2FE5852AQ35070505-1009DA89-0C10-4707-86C8-D0B260C81D92Q35077892-832C5ACB-80AA-4D6D-895E-C43AEA050A01Q35897609-C6D622DC-C623-4192-A1D4-DE85CBD0F8C4Q35914345-4E818D59-7BB8-47BA-9BB7-8270173BDFB2Q36246429-66D93277-6018-406D-B4B3-74612C58BE78Q36263882-0F777689-3CAD-4E3C-AE32-094904D26406Q36266896-A2EC194D-5C5F-4DE5-9C08-F6BA797373DBQ36315159-448BF4AB-E53B-4469-8324-00A8E9D03394Q36338294-1462BCC3-38CA-4785-8CD2-8C6BF89CD4E0Q36371267-9336291A-D23C-4239-8F48-2FCF0B3A1D1CQ36401291-9599C0C7-E353-4830-AC4C-1FBF14F8B3F9Q36464353-1742F92F-B3C1-417A-8C25-4AD82C6D9750Q36483809-0AADD545-BEC0-4EAD-BD29-E641614339F6Q36684360-74754A92-79EB-4FF8-849A-7C3005101DFAQ36784740-BFAD17CB-A4CC-4C53-B41D-9C90FFBD09E7Q36838539-33409445-2B92-4E74-A042-4648FBFE7735Q37188620-D6971A5C-351D-4E88-A359-6C5D095C8C84Q37252613-E8744505-5086-408B-B48B-8135769A02E3
P2860
Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Generation of atypical pulmona ...... f respiratory syncytial virus.
@ast
Generation of atypical pulmona ...... f respiratory syncytial virus.
@en
type
label
Generation of atypical pulmona ...... f respiratory syncytial virus.
@ast
Generation of atypical pulmona ...... f respiratory syncytial virus.
@en
prefLabel
Generation of atypical pulmona ...... f respiratory syncytial virus.
@ast
Generation of atypical pulmona ...... f respiratory syncytial virus.
@en
P2093
P2860
P1433
P1476
Generation of atypical pulmona ...... f respiratory syncytial virus.
@en
P2093
P2860
P304
P407
P577
1996-11-01T00:00:00Z